CD8A and COVID-19: Notably, Shahbazi et al. [42], who adjusted linear mixed effects models for potential clinical confounders (e.g., age, sex, and comorbidities), observed that critically ill COVID-19 patients had higher frequencies of TIM3+CD8+ and TIM3+CD39+CD8+ cells than non-critical patients.